Hunan Jiudian Pharmaceutical Future Growth
Future criteria checks 4/6
Hunan Jiudian Pharmaceutical is forecast to grow earnings and revenue by 25.5% and 18.1% per annum respectively. EPS is expected to grow by 25.2% per annum. Return on equity is forecast to be 24.4% in 3 years.
Key information
25.5%
Earnings growth rate
25.2%
EPS growth rate
| Pharmaceuticals earnings growth | 18.7% |
| Revenue growth rate | 18.1% |
| Future return on equity | 24.4% |
| Analyst coverage | Good |
| Last updated | 06 Nov 2024 |
Recent future growth updates
No updates
Recent updates
Do Hunan Jiudian Pharmaceutical's (SZSE:300705) Earnings Warrant Your Attention?
Oct 22
With Hunan Jiudian Pharmaceutical Co., Ltd. (SZSE:300705) It Looks Like You'll Get What You Pay For
Aug 12Here's Why Hunan Jiudian Pharmaceutical (SZSE:300705) Can Manage Its Debt Responsibly
Jun 23Hunan Jiudian Pharmaceutical (SZSE:300705) Is Increasing Its Dividend To CN¥0.321
May 21Here's Why We Think Hunan Jiudian Pharmaceutical (SZSE:300705) Might Deserve Your Attention Today
Apr 12Earnings Not Telling The Story For Hunan Jiudian Pharmaceutical Co., Ltd. (SZSE:300705) After Shares Rise 27%
Mar 04Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 4,436 | 874 | 542 | 887 | 6 |
| 12/31/2025 | 3,750 | 673 | 369 | 634 | 7 |
| 12/31/2024 | 3,162 | 521 | 279 | 623 | 7 |
| 9/30/2024 | 2,945 | 508 | 235 | 646 | N/A |
| 6/30/2024 | 2,841 | 455 | 286 | 652 | N/A |
| 3/31/2024 | 2,782 | 417 | 192 | 571 | N/A |
| 12/31/2023 | 2,693 | 368 | 4 | 431 | N/A |
| 9/30/2023 | 2,620 | 371 | 60 | 490 | N/A |
| 6/30/2023 | 2,513 | 338 | -86 | 427 | N/A |
| 3/31/2023 | 2,379 | 291 | -162 | 369 | N/A |
| 1/1/2023 | 2,326 | 270 | -144 | 269 | N/A |
| 9/30/2022 | 2,097 | 243 | -55 | 262 | N/A |
| 6/30/2022 | 1,927 | 221 | -16 | 163 | N/A |
| 3/31/2022 | 1,799 | 214 | 57 | 176 | N/A |
| 1/1/2022 | 1,628 | 204 | 65 | 191 | N/A |
| 9/30/2021 | 1,451 | 196 | 41 | 149 | N/A |
| 6/30/2021 | 1,317 | 162 | 48 | 166 | N/A |
| 3/31/2021 | 1,096 | 122 | 63 | 148 | N/A |
| 12/31/2020 | 978 | 82 | 72 | 150 | N/A |
| 9/30/2020 | 921 | 72 | 83 | 183 | N/A |
| 6/30/2020 | 891 | 59 | 31 | 144 | N/A |
| 3/31/2020 | 906 | 52 | -15 | 127 | N/A |
| 12/31/2019 | 924 | 55 | -91 | 91 | N/A |
| 9/30/2019 | 900 | 65 | -162 | 64 | N/A |
| 6/30/2019 | 867 | 73 | -176 | 62 | N/A |
| 3/31/2019 | 811 | 70 | -200 | 76 | N/A |
| 12/31/2018 | 801 | 72 | -189 | 68 | N/A |
| 9/30/2018 | 746 | 67 | -160 | 40 | N/A |
| 6/30/2018 | 680 | 72 | N/A | 65 | N/A |
| 3/31/2018 | 613 | 71 | N/A | 56 | N/A |
| 12/31/2017 | 535 | 69 | N/A | 80 | N/A |
| 9/30/2017 | 472 | 72 | N/A | 86 | N/A |
| 6/30/2017 | 430 | 62 | N/A | 75 | N/A |
| 3/31/2017 | 385 | 56 | N/A | 52 | N/A |
| 12/31/2016 | 376 | 55 | N/A | 55 | N/A |
| 9/30/2016 | 334 | 39 | N/A | 35 | N/A |
| 6/30/2016 | 320 | 38 | N/A | 32 | N/A |
| 3/31/2016 | 305 | 41 | N/A | 32 | N/A |
| 12/31/2015 | 290 | 45 | N/A | 32 | N/A |
| 9/30/2015 | 281 | 43 | N/A | 30 | N/A |
| 6/30/2015 | 272 | 40 | N/A | 28 | N/A |
| 3/31/2015 | 269 | 41 | N/A | 34 | N/A |
| 12/31/2014 | 266 | 41 | N/A | 40 | N/A |
| 12/31/2013 | 241 | 36 | N/A | 31 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 300705's forecast earnings growth (25.5% per year) is above the savings rate (2.8%).
Earnings vs Market: 300705's earnings (25.5% per year) are forecast to grow slower than the CN market (26.1% per year).
High Growth Earnings: 300705's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 300705's revenue (18.1% per year) is forecast to grow faster than the CN market (13.8% per year).
High Growth Revenue: 300705's revenue (18.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 300705's Return on Equity is forecast to be high in 3 years time (24.4%)